CACanadaRules
Mounjaro cardiovascular indication approved by Health Canada after a head to head trial with Trulicity
Health Canada approved Mounjaro to lower the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, based on the SURPASS-CVOT trial against dulaglutide.